Screening of medicinal mushroom strains with antimicrobial activity and polysaccharides production

Abstract

AbstractObjectivesThis study aimed to determine the antimicrobial activity of culture fluid and mycelial mass of selectedHericiumstrains from the IBK Mushroom Culture Collection (Kyiv, Ukraine) against bacteria and fungi, as well as to evaluate the potential of these mushrooms for biomass and extracellular polysaccharides production.MethodsThe antimicrobial activity of ethyl acetate extracts of culture fluid and aqueous-ethyl extracts of mycelial mass for threeHericiumspecies:Hericium cirrhatumIBK 2393,Hericium coralloidesIBK 2332, andHericium erinaceusIBK 2530 against Gram-positiveBacillus subtilis,Staphylococcus aureus, and Gram-negativeEscherichia coli,Klebsiella pneumoniae,Pseudomonas aureginosabacteria as well asAspergillus niger,Penicillium polonicum, andMucor globosusfungi by the disk diffusion method was conducted. Analysis of the minimum inhibitory concentration was carried out according to the broth dilution method.ResultsHigh antimicrobial activity of culture fluid extracts ofHericiummushroom species againstS. aureuswas established after 14–21 days of cultivation. No effects ofHericiumextracts againstA. niger,P. polonicum, andM. globosuswere observed. On the 7th day of submerged cultivation, the studied strains produced the maximum yield of extracellular polysaccharides. The most promising extracellular polysaccharide (EPS) producers were strains ofH. coralloidesIBK 2332 (1.89 g/L) andH. erinaceusIBK 2530 (1.90 g/L). The maximal value of biomass was produced byH. cirrhatumIBK 2393 on the 21st day of submerged cultivation (17.45 g/L).ConclusionsHericiummushrooms have significant potential for the development of new drugs with health benefits properties.